Rare disease diagnosis boost: new study eyes key clues in ASMD patients

NCT ID NCT07274826

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at symptoms and lab tests to help doctors better diagnose acid sphingomyelinase deficiency (ASMD), also known as Niemann-Pick disease, a rare genetic disorder. Researchers will track changes in spleen and liver size using ultrasound over 12 months in 7 patients. The goal is to improve how this condition is identified and monitored.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACID SPHINGOMYELINASE DEFICIENCY (ASMD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sohag University Hospital

    Sohag, Egypt